Care Ratings gains on launching PaRRVA with NSE

Care Ratings Ltd. | Ratings | BFSI | BSE: 534804 | NSE: CARERATING

04 May 2026 Evaluate

Care Ratings is currently trading at Rs. 1693.75, up by 26.70 points or 1.60% from its previous closing of Rs. 1667.05 on the BSE.

The scrip opened at Rs. 1700.40 and has touched a high and low of Rs. 1725.00 and Rs. 1683.00 respectively. So far 1587 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1964.80 on 11-Jun-2025 and a 52 week low of Rs. 1150.00 on 12-May-2025.

Last one week high and low of the scrip stood at Rs. 1723.50 and Rs. 1540.05 respectively. The current market cap of the company is Rs. 5095.69 crore.

The institutions holding in the company stood at 54.64%, while Non-Institutions held 45.37% stake in the company.

Care Ratings, in collaboration with the National Stock Exchange of India (NSE), has commercially launched Past Risk and Return Verification Agency (PaRRVA), a first-of-its-kind global initiative conceptualised by SEBI. As India’s investor base continues to grow, PaRRVA is well-positioned to become a key enabler of transparent communication of performance verification in the securities market. This unique framework validates risk-return metrics for Investment Advisors, Research Analysts, and Trading Members, thereby ensuring greater credibility, compliance, and investor trust.
PaRRVA is designed to bring transparency and standardisation to performance claims made by financial intermediaries. It ensures that all risk-return metrics presented to investors are independently verified and compliant with the verification methodologies developed in line with recommendations from Industry participants.

Intermediaries can submit their recommendations through secure API-based integration or file uploads, following which PaRRVA – PDC conducts a comprehensive validation and generates risk and return metrics. Close to 50 different risk and return matrices are computed from transaction data directly sourced from stock exchanges and clearing corporations and will be disseminated to investors via the PaRRVA platform. Investors can also view the reports by scanning the QR code or by using a link that directs them to the official PaRRVA portal.

Care Ratings provides the entire spectrum of credit rating that helps the corporates to raise capital for their various requirements and assists the investors to form an informed investment decision based on the credit risk and their own risk-return expectations.

Care Ratings Share Price

1694.85 27.80 (1.67%)

04-May-2026 16:59 View Price Chart

Peers

Company Name	CMP
CRISIL	4237.05
ICRA	5450.20
Care Ratings	1694.85
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.